Division Title
Safety

Institutional Biosafety Committee

Institutional Biosafety Committee

The NIH Institutional Biosafety Committee (IBC) provides recommendations to the Director of the NIH or his designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents, their vectors, and recombinant DNA. The committee serves as an advisory body to the Division of Occupational Health and Safety (DOHS), Office of Research Services (ORS).

Read more from the Charter for the NIH Institutional Biosafety Committee. 

Membership Roster

 

Name​

​Affiliation

Dr. Steven Feldman, Ph.D. Chairman, Virologist​

Surgery Branch 

NCI

Dr. Yasmine Belkaid, Ph.D.
Senior Investigator

Laboratory of Parasitic Diseases
NIAID

​Dr. Jeremy Davis, M.D.

​Thoracic & Gastrointestinal Oncology Branch 
NCI

​Dr. Robert Craigie, Ph.D. 
Molecular Biologist

​Molecular Virology Section
NIDDK

​Dr. Kevin L. Holmes, Ph.D.
Biologist

​Flow Cytometry Section

NIAID

​Dr. Harry Malech, M.D.
Clinician

​Laboratory of Host Defenses
NIAID

​Dr. Steven Denny, DVM
Animal Programs

​Office of Animal Care and Use 
OACU

​Deborah A. Michaels

​Community Member

​Mr. Carl Seils

​Community Member

​Ms. Jocelyn Dunford Weissman
Senior Research Associate

​Experimental Immunology Branch 
NCI

​Christine Maisano

​Scientific Technical Writer

Dr. Richard Baumann, Ph.D. NIH Biological Safety Officer (BSO) IBC Executive Secretary​

ORS, Division of Occupational Health and Safety​​

Adam Clarkson, M.P.H., C.B.S.P. NIH Associate Biological Safety Officer​

ORS, Division of Occupational Health and Safety​ ​